the 3 levels of aging therapeutics @TheSheekeyScienceShow
the 3 levels of aging therapeutics  @TheSheekeyScienceShow
Uploaded February 2026 | Updated September 2026, 3 weeks ago
Why do so many anti-aging drugs work in mice but fail in humans? It turns out, we might be aging in fundamentally different ways. A new "minimal model" from physicists Peter Fedichev and Jan Gruber suggests that aging isn't a chaotic mess of billions of problems, but a process governed by just three macroscopic variables.

In this video, I break down their paper to explain why current "Level 1" interventions (like senolytics and cellular reprogramming) might only improve healthspan, not maximum lifespan. We'll explore the difference between "stable" species (humans) and "unstable" ones (mice), and reveal the physics-based roadmap—Level 2 and Level 3—required to actually extend the human lifespan limit beyond 120 years.

Find me on Twitter - twitter.com/EleanorSheekey

Support the channel
through PayPal - paypal.me/sheekeyscience?country.x=GB&locale.x=en_GB
through Patreon - patreon.com/TheSheekeyScienceShow

TIMESTAMPS
0:00 – Why 300 aging theories might be wrong (The Physics of Universality)
3:45 – The 3 variables that control your lifespan
7:12 – Why mice are biologically "broken" compared to humans
9:58 – The 3 Levels of Intervention: Why reprogramming isn't enough (yet)
13:20 – The only way to actually break the 120-year limit

REFERENCES
Fedichev, P. & Gruber, J. (2024). A Minimal Model Explains Aging Regimes and Guides Intervention Strategies. bioRxiv. [Preprint]
Pyrkov, T. V., et al. (2021). Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts ultimate limit of human lifespan. Nature Communications, 12, 2765.
Avchaciov, K., et al. (2022). Unsupervised learning of aging principles from longitudinal data. Nature Communications, 13, 6529.
Perevoshchikova, K. & Fedichev, P. O. (2024). Differential Responses of Dynamic and Entropic Aging Factors to Longevity Interventions. bioRxiv.
Tarkhov, A. E., et al. (2024). Universal transcriptomic signature of age reveals the temporal scaling of Caenorhabditis elegans aging trajectories. AgingBio, 2, 1–16.
Tong, H., et al. (2024). Quantifying the stochastic component of epigenetic aging. Nature Aging, 4, 886–897.
Meyer, D. H. & Schumacher, B. (2024). Biologically informative or merely random? The stochastic nature of epigenetic clocks. Nature Aging, 4, 871–885.
Sinclair, D. A. & Guarente, L. (1997). Extrachromosomal rDNA circles—a cause of aging in yeast. Cell, 91(7), 1033–1042.
Medvedev, Z. A. (1990). An attempt at a rational classification of theories of ageing. Biological Reviews, 65(3), 375–398.

Please note that The Sheekey Science Show is distinct from Eleanor Sheekey's teaching and research roles. The information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Sheekey Science Show and guests assume no liability for the application of the information discussed.

Icons in intro; "freepik.com/free-photos-vectors/background"Background vector created by freepik - freepik.com
the 3 levels of aging therapeuticsIs aging a loss of biological self?one gene for cell rejuvenation?Inside a Longevity Biotech Company - Shift Bioscience (Cellular Reprogramming)3 Rejuvenation Strategies For Aging.OpenAI Meets Longevity: Inside the Retro Biosciences Partnership That Beat EvolutionHow Synthetic Biology will Grow the Future - Inside Ginkgo Bioworks (literally)A senolytic vaccine for aging?Evolution of aging - could it be adaptive? - Peter LidskyCRISPRoff - the new frontier for reversible epigenetic editingcan this new enzyme reverse aging?Healing tissue from the inside out - infusible biomaterial.
The Sheekey Science Show |

the 3 levels of aging therapeutics

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER